Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) Stock Information | RedChip

Virpax Pharmaceuticals Inc. (NASDAQ: VRPX)


$0.7198
+0.0008 ( +0.11% ) 62.8K

Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.

Market Data


Open


$0.7198

Previous close


$0.7190

Volume


62.8K

Market cap


$3.51M

Day range


$0.6680 - $0.7230

52 week range


$0.3625 - $8.0000

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Dec 07, 2023
pre Proxies and info statements 4 Nov 21, 2023
8-k 8K-related 14 Nov 17, 2023
8-k 8K-related 14 Nov 17, 2023
8-k 8K-related 14 Nov 16, 2023
nt Quarterly Reports 1 Nov 15, 2023
8-k 8K-related 12 Oct 11, 2023
3 Insider transactions 2 Oct 03, 2023
8-k 8K-related 14 Sep 05, 2023
8-k 8K-related 13 Aug 16, 2023

Latest News